Studies on post-mortem brains have shown increased microglial activation based on cell morphology and Iba1 and CD68 immunoreactivity in C9-FTLD and C9-ALS vs. sporadic FTLD and ALS cases. The gene discussed is CD68; the disease is amyotrophic lateral sclerosis.